Latest Breaking News On - கில்லியன் பக்லி - Page 1 : comparemela.com
5 areas of tech to watch, according to investors
siliconrepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siliconrepublic.com Daily Mail and Mail on Sunday newspapers.
Irish Venture Capital Association names new chairperson
rte.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rte.ie Daily Mail and Mail on Sunday newspapers.
Venture capital funding to Irish technology firms up by 8.9% Funding ‘appears to have shaken off any restrictions caused by Covid-19’
Mon, May 10, 2021, 08:11
Venture capital funding to Irish technology firms increased by 8.9 per cent to €249.4 million in the first quarter of 2021, up from €228.9m in the same period last year, according to the Irish Venture Capital Association (IVCA) VenturePulse survey.
“Funding appears to have shaken off any restrictions caused by Covid-19,” said IVCA chairwoman Gillian Buckley.
“This is reflected in the fact that the number of deals increased by 65 per cent to 74, compared to 48 in the same quarter last year, largely driven by a welcome recovery in early stage funding.”
Uptick in early-stage funding deals starts 2021 on ‘positive’ note
Gillian Buckley, chair of the IVCA. Image: IVCA
Figures from the Irish Venture Capital Association show that seed and early-stage deals have recovered partially after a tough 2020.
Early-stage funding deals in Ireland saw a slight bounce back in the first quarter of 2021 after a worrying decline in 2020.
Overall funding in the first quarter of the year, according to deals tracked by the Irish Venture Capital Association (IVCA), stood at €249.4m. This is up 8.9pc from the same period in 2020.
“Funding appears to have shaken off any restrictions caused by Covid-19,” Gillian Buckley, chair of the IVCA, said.
Sligo biotech start-up Nektr secures €1m in funding
Frank Boyle, CEO of Nektr Technologies. Image: WDC
The start-up is developing a compound that could help in tackling antibiotic resistance in humans and animals.
Nektr Technologies, a Sligo-based biotech start-up, has raised €1m in funding to bring its technology from trial stages to market.
It is developing a synthetic antimicrobial compound that could make treatments like antibiotics more effective for humans and animals.
Half of the funding round comes from the Western Development Commission (WDC), with other backers including Enterprise Ireland also investing.
Nektr’s technology, called A3IS, is hoped to be able to combat against multi-drug resistant pathogens. The start-up is exploring the application of its compound in dermatological conditions, nasal decontamination and medical device coatings.
vimarsana © 2020. All Rights Reserved.